BROWN UNIVERSITY
Artemisinin Resistance in Africa: its emergence and evolution in Rwanda
Artemisinin Resistance in Africa: its emergence and evolution in Rwanda is a funding opportunity from BROWN UNIVERSITY, up to 715370, closing July 31, 2026.
Jul 31, 2026
(0d left)Overview
ABSTRACT Artemisinin combination therapies (ACTs) are the mainstay antimalarial treatment combating Plasmodium falciparum malaria around the world. While resistance is widespread in Asia, it has not yet been observed in Africa where the majority of the global morbidity and mortality occurs. Artemisinin and ACT…